Loading...
Found 594 results for IU Health Enterprise System
A listing of IU Health Enterprise System medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
A phase 1, open-label, single arm study to evaluate pharmacokinetics, safety, and tolerability of Saroglitazar Magnesium dosed on alternate days in subjects having moderate hepatic impairment with cirrhosis due to cholestatic liver disease
R
Raj Vuppalanchi, MD
To evaluate PK after Saroglitazar Magnesium 1 mg dose on alternate days in subjects with moderate hepatic impairment with cirrhosis due to CLD based on Child-Pugh-Turcotte (CPT) score.To assess safety and tolerability of Sa-roglitazar Magnesium 1 mg dose on alter-nate days in subjects with moderate hepatic impairment with cirrhosis due …
Geometric Engineering of Liver Organoid Culture in Pediatric Liver Diseases
C
Chao Jarasvaraparn
What is the purpose of this study?Chronic liver disease (CLD) in children can be caused by a variety of conditions and have serious consequences if left untreated. Liver organoids are defined as 3D structure derived from human liver tissue and is a promising new approach to treating liver disease in …
Effect of Bariatric Outreach Clinic on Rural Bariatric Surgery Patients
R
Rosalie Carr
What is the purpose of this study?We hypothesize that decreased travel time to receive perioperative bariatric surgery care will increase patient satisfaction and enrollment into the Indiana University Health bariatric surgery program. Improved patient satisfaction may also improve patient compliance and surgical outcomes.Goals: Assess patient satisfaction with the IUH West bariatric …
Fiber and anthocyanin complexes as direct modifiers of microbial dysbiosis in pediatric ulcerative colitis
T
Tina Zhang
The study objective is to identify fiber combinations and fiber-anthocyanin complexes which support a broad spectrum of beneficial microbes which enhance fiber fermentation and increase Short Chain Fatty Acid production therefore promoting gut health with decreased inflammation and systemic benefits.THIS STUDY IS ENROLLING BY INVITATION ONLY - Study participants will …
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY)
M
Marc Rovner
The purpose of this study is to compare the effect of tezepelumab with placebo on moderate or severe COPD exacerbations in participants with moderate to very severe COPD. THIS STUDY IS ENROLLING BY INVITATION ONLY
Evaluation of genetic mutations in African American with glaucoma associated with long anterior zonules (LAZ)
W
Weiming Mao
What is the purpose of this study?Long anterior zonules (LAZ) is the presence of the zonular fibers (a tissue that holds the lens in place) attaching to the anterior part of the lens. LAZ is a rare disease and is genetically associated with certain gene mutations. It has been reported …
Clinical Utility Study to Determine Impact of PanCystPro Assay on Physician Decision-making in the Management of Pancreatic Cystic Lesions
M
Mohammad Al-Haddad, MD
The purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts. The PanCystPro test measures glucose, carcinoembryonic antigen (CEA), and gastricsin biomarkers on fluid obtained from a pancreatic cyst. The test reports if the cyst fluid …
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Efficacy of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Patients with Idiopathic Pulmonary Fibrosis
R
Ryan Boente
This Phase 2, randomized, double-blind, placebo-controlled, multi-center study will compare the safety, tolerability, and efficacy of inhaled LTI-03 to placebo in participants diagnosed with IPF within 5 years of Screening who may be receiving standard of care (SoC) antifibrotic therapy.LTI-03 is an experimental medication breathed into the lungs using an …
Ep0239 Sleep Disturbances, Behavior, Activities Of Daily Living, And Caregiver Burden Among Patients Diagnosed With Dravet Syndrome And Lennox-Gastaut Syndrome Initiating Treatment With Fenfluramine (Fintepla): A Prospective Multicenter Study
J
Jason Santiago
Fenfluramine (Fintepla®) is currently approved in your country for the treatment of seizures associated with Dravet syndrome (DS) and for Lennox-Gastaut syndrome (LGS). In addition to seizures, almost all patients experience multiple and significant non-seizure disorders. This study aims to describe the treatment-related impact of fenfluramine on non-seizure outcomes, ie, …
An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or Abl-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia
S
Sandeep Batra, MD
This phase III trial compares the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemotherapy versus dasatinib or imatinib and standard chemotherapy for treating patients with Philadelphia chromosome positive (PH+) or ABL-class Philadelphia chromosome-like (Ph-Like) B-Cell acute lymphoblastic leukemia (B-ALL). Blinatumomab is a bispecific antibody that …
Please choose between Voice or SMS based delivery of verification code
or